175 related articles for article (PubMed ID: 27207169)
21. Cortical oxygen extraction fraction using quantitative BOLD MRI and cerebral blood flow during vasodilation.
Le LNN; Wheeler GJ; Holy EN; Donnay CA; Blockley NP; Yee AH; Ng KL; Fan AP
Front Physiol; 2023; 14():1231793. PubMed ID: 37869717
[No Abstract] [Full Text] [Related]
22. Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.
Donahue MJ; Ayad M; Moore R; van Osch M; Singer R; Clemmons P; Strother M
J Magn Reson Imaging; 2013 Nov; 38(5):1129-39. PubMed ID: 23440909
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of renal oxygenation change under the influence of carbogen breathing using a dynamic R
Wang C; Zhao K; Zhang R; Jiang L; Wang R; Zhang X; Wang H; Jin L; Zhang J; Wang X; Fang J
NMR Biomed; 2016 Nov; 29(11):1601-1607. PubMed ID: 27670144
[TBL] [Abstract][Full Text] [Related]
24. [Cerebral hemodynamics in adult ischemic-type patients with moyamoya disease compared with those of atherothrombotic middle cerebral artery occlusion].
Idei M; Yamane K; Nishida M; Manabe K; Yokota A
No To Shinkei; 2005 Feb; 57(2):131-5. PubMed ID: 15856759
[TBL] [Abstract][Full Text] [Related]
25. [Vascular responses in cerebrovascular "Moyamoya" disease--evaluated by positron emission tomography].
Tomura N; Kanno I; Shishido F; Higano S; Fujita H; Inugami A; Tabata K; Uemura K; Sayama I; Yasui N
No To Shinkei; 1989 Sep; 41(9):895-904. PubMed ID: 2511909
[TBL] [Abstract][Full Text] [Related]
26. Value of transverse relaxometry difference methods for iron in human brain.
Uddin MN; Lebel RM; Wilman AH
Magn Reson Imaging; 2016 Jan; 34(1):51-9. PubMed ID: 26435459
[TBL] [Abstract][Full Text] [Related]
27. Brain region and activity-dependent properties of M for calibrated fMRI.
Shu CY; Herman P; Coman D; Sanganahalli BG; Wang H; Juchem C; Rothman DL; de Graaf RA; Hyder F
Neuroimage; 2016 Jan; 125():848-856. PubMed ID: 26529646
[TBL] [Abstract][Full Text] [Related]
28. Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis.
Donahue MJ; Dethrage LM; Faraco CC; Jordan LC; Clemmons P; Singer R; Mocco J; Shyr Y; Desai A; O'Duffy A; Riebau D; Hermann L; Connors J; Kirshner H; Strother MK
Stroke; 2014 Aug; 45(8):2335-41. PubMed ID: 24938845
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic contribution of transdural collateral flow in adult patients with moyamoya disease.
Hong JM; Hong YH; Lee SJ; Lee SE; Lee JS; Shin DH
Neurol Sci; 2016 Dec; 37(12):1969-1977. PubMed ID: 27590482
[TBL] [Abstract][Full Text] [Related]
30. Substraction acetazolamide SPECT co-registered to MRI in moyamoya disease: quantitative cerebrovascular reserve map.
Cortés J; Arias-Rivas S; Rodriguez-Yañez M; Blanco M; Aguiar P
Clin Nucl Med; 2014 Apr; 39(4):399-401. PubMed ID: 23510893
[TBL] [Abstract][Full Text] [Related]
31. A mathematical model for temporal cerebral blood flow response to acetazolamide evaluated in patients with Moyamoya disease.
Fahlström M; Sousa JM; Svedung Wettervik T; Berglund J; Enblad P; Lewén A; Wikström J
Magn Reson Imaging; 2024 Jul; 110():35-42. PubMed ID: 38574981
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of renal oxygenation in rat by using R2' at 3-T magnetic resonance: initial observation.
Yang X; Cao J; Wang X; Li X; Xu Y; Jiang X
Acad Radiol; 2008 Jul; 15(7):912-8. PubMed ID: 18572128
[TBL] [Abstract][Full Text] [Related]
33. Effect of respiratory hyperoxic challenge on magnetic susceptibility in human brain assessed by quantitative susceptibility mapping (QSM).
Özbay PS; Rossi C; Kocian R; Redle M; Boss A; Pruessmann KP; Nanz D
NMR Biomed; 2015 Dec; 28(12):1688-96. PubMed ID: 26484968
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cerebral blood flow and hemodynamic reserve in symptomatic moyamoya disease using stable Xenon-CT blood flow.
Horowitz M; Yonas H; Albright AL
Surg Neurol; 1995 Sep; 44(3):251-61; discussion 262. PubMed ID: 8545777
[TBL] [Abstract][Full Text] [Related]
35. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.
Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Nagamachi S; Kodama T; Watanabe K; Ueda T; Wakisaka S
J Nucl Med; 1994 Jan; 35(1):44-50. PubMed ID: 8271059
[TBL] [Abstract][Full Text] [Related]
36. The relationship between blood flow impairment and oxygen depletion in acute ischemic stroke imaged with magnetic resonance imaging.
Seiler A; Blockley NP; Deichmann R; Nöth U; Singer OC; Chappell MA; Klein JC; Wagner M
J Cereb Blood Flow Metab; 2019 Mar; 39(3):454-465. PubMed ID: 28929836
[TBL] [Abstract][Full Text] [Related]
37. Cerebral blood oxygenation changes induced by bypass blood flow in moyamoya disease and non-moyamoya cerebral ischaemic disease.
Hoshino T; Sakatani K; Kano T; Murata Y; Katayama Y
Acta Neurochir (Wien); 2006 May; 148(5):551-7; discussion 557. PubMed ID: 16467961
[TBL] [Abstract][Full Text] [Related]
38. BOLD quantified renal pO2 is sensitive to pharmacological challenges in rats.
Thacker J; Zhang JL; Franklin T; Prasad P
Magn Reson Med; 2017 Jul; 78(1):297-302. PubMed ID: 27501515
[TBL] [Abstract][Full Text] [Related]
39. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
[TBL] [Abstract][Full Text] [Related]
40. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
